Scotia Capital’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-6,841
| Closed | -$284K | – | 900 |
|
|
2024
Q4 | $284K | Sell |
6,841
-12,735
| -65% | -$530K | ﹤0.01% | 717 |
|
|
2024
Q3 | $1.31M | Buy |
19,576
+6,400
| +49% | +$428K | 0.01% | 460 |
|
|
2024
Q2 | $1.56M | Sell |
13,176
-458
| -3% | -$54.4K | 0.01% | 417 |
|
|
2024
Q1 | $1.45M | Buy |
13,634
+866
| +7% | +$92.3K | 0.01% | 426 |
|
|
2023
Q4 | $1.27M | Sell |
12,768
-769
| -6% | -$76.5K | 0.01% | 424 |
|
|
2023
Q3 | $1.4M | Buy |
13,537
+5,489
| +68% | +$567K | 0.01% | 391 |
|
|
2023
Q2 | $978K | Sell |
8,048
-9,569
| -54% | -$1.16M | 0.01% | 448 |
|
|
2023
Q1 | $2.71M | Sell |
17,617
-808
| -4% | -$124K | 0.02% | 308 |
|
|
2022
Q4 | $3.31M | Sell |
18,425
-2,765
| -13% | -$497K | 0.03% | 278 |
|
|
2022
Q3 | $2.51M | Buy |
21,190
+56
| +0.3% | +$6.62K | 0.02% | 314 |
|
|
2022
Q2 | $3.02M | Sell |
21,134
-519
| -2% | -$74.1K | 0.02% | 296 |
|
|
2022
Q1 | $3.73M | Buy |
21,653
+13,395
| +162% | +$2.31M | 0.02% | 302 |
|
|
2021
Q4 | $2.1M | Sell |
8,258
-7,045
| -46% | -$1.79M | 0.01% | 393 |
|
|
2021
Q3 | $5.89M | Buy |
15,303
+4,611
| +43% | +$1.77M | 0.04% | 217 |
|
|
2021
Q2 | $2.51M | Buy |
10,692
+5,431
| +103% | +$1.28M | 0.02% | 351 |
|
|
2021
Q1 | $689K | Buy |
5,261
+2,351
| +81% | +$308K | 0.01% | 548 |
|
|
2020
Q4 | $304K | Sell |
2,910
-2,758
| -49% | -$288K | ﹤0.01% | 629 |
|
|
2020
Q3 | $401K | Buy |
5,668
+1,474
| +35% | +$104K | ﹤0.01% | 540 |
|
|
2020
Q2 | $269K | Buy |
+4,194
| New | +$269K | ﹤0.01% | 534 |
|